Abbott’s Everyday Products Dominate Danaher’s Biotech Gear Market
Abbott Laboratories posted a stronger quarter driven by consumer-facing devices and diagnostics, while Danaher faced ...
Consider index investing for broad diversification and low costs after establishing risk tolerance and goals. This guide points to ideal moments.
13,296 articlesAbbott Laboratories posted a stronger quarter driven by consumer-facing devices and diagnostics, while Danaher faced ...
From a tiny boat-insurer niche to a public company, Hagerty’s story is a case study in branding, community, and strat...
A Detroit autoworker’s dream of winning margins meets a global market that’s increasingly dependent on China. This ar...
A single director's sale at MannKind raises questions about the durability of royalty streams. This analysis breaks d...
Massive AI budgets are on the horizon. This article breaks down who will spend the most, why the opportunity matters,...
Snap enters 2026 with a volatile but potentially rewarding path. Analysts weigh user growth, ad monetization, and new...
A pivotal license extension in Ghana fuels a surge in Kosmos Energy. This article breaks down what the move means for...
Investors want to know if now is the time figma stock? This guide breaks down how to evaluate Figma stock, what metri...
This piece examines which stocks people actually search for and why those trends matter. Learn how to separate curios...
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
NuScale Power stock has been under pressure as investors digest macro concerns and regulatory headwinds. This guide b...
As Ardent Health closes 2025, the Q4 results shed light on margins, volumes, and balance-sheet health. This analysis ...